FK-506, a novel immunosuppressant, has been isolated from the fermentation broth of Streptomyces tsukuhaensis No. 9993 as colorless prism and the molecular formula was determined as C44H69NOi2«H2O. The compoundsuppressed immuneresponses in vitro and in vivo with mice. This immunosuppressiveeffect was more potent than that of ciclosporin.
FK-506, a novel immunosuppressant, has been isolated from the fermentation broth of Streptomyces tsukuhaensis No. 9993 as colorless prism and the molecular formula was determined as C44H69NOi2«H2O. The compoundsuppressed immuneresponses in vitro and in vivo with mice. This immunosuppressiveeffect was more potent than that of ciclosporin.
Ciclosporin (CS), a fungal metabolite, is an effective immunosuppressant with low myelotoxicity0 and has been used successfully as the primary drug to suppress the rejection of transplants. 2"0 It is now well established that CS inhibits the production of T cell-derived soluble mediators such as interleukin 2 (IL-2), interleukin 3 (IL-3) and gamma-interferon (IFN-f) induced by antigens and lectins.5~8) The immunosuppressive agent which would attack specific target sites of cell are expected to provide a useful prototype o drugs for immunotherapy. Accordingly, we hav< tested a wide range of fermented broths fo specific inhibitory effects on IL-2 production. As a result, a strain of Streptomyces tsukuba ensis No. 9993 was found to produce the poten immunosuppressive agent, designated by th< code number of FK-506. Taxonomic study or this strain will be presented in a separate paper.9) In this paper, we describe the fermentation, isolation procedures and some chemical and biological properties of FK-506. As shown in Fig. 1 , FK-506 is a neutral macrolide. Determination of the chemical structure of FK-506 will be published elsewhere.10)
Materials and Methods
Fermentati on A seed medium 100 ml containing glycerol 1 %, corn starch 1 %, glucose 0.5%, cotton seed meal 1 %, corn steep liquor 0.5% and calcium carbonate 0.2% at pH 6.5 was poured into a 500-ml Erlenmeyer flask and sterilized at 120°C for 30 minutes. A loopful of slant culture of S. tsukubaensis No. SEPT. 1987 9993 was inoculated to the medium and cultured at 30°C for 4 days. The resultant culture was transferred to the same seed medium(20 liters) in 30 liters jar fermentor which had been sterilized at 120°C for 30 minutes in advance. After the culture was performed at 30°C for 2 days, aerated at 20 liters per minutes and agitated at 300 rpm, 16 liters of the preculture was inoculated to a fermentation medium 1,600 liters containing soluble starch 4.5 %, corn steep liquor 1 %, dried yeast 1 %, calcium carbonate 0.1 % and Adekanol (Asahi Denka Co.) 0.1 % at pH 6.8 in a 2-kiloliter tank which had been sterilized at 120°C for 30 minutes in advance. This was cultured at 30°C for 4 days with agitation at 170 rpm and with air flow of 1,600 liters per minute.
Antimicrobial Activities Minimuminhibitory concentration (MIC) test was conducted by the usual serial agar dilution method, using a nutrient agar for antibacterial test and a Sabouraud's agar for antifungal test which was incubated at 30°C for 24 hours. MICvalue is expressed as the minimumconcentration which inhibits growth of the microorganisms.
Mice
Specific pathogen free BALB/C, C57BL/6, BDFX, (female, 6-7 weeks old) and C3H/He (male, 6~1 weeks old) mice were obtained from Charles River Japan Inc. (Kanagawa, Japan). The MLRtest was performed in microtiter plates, with each well containing 5 x lO5 C57BL/6 responder cells (H-2b), 5 x 105 mitomycin C treated (25 jug/ml mitomycin C at 37°C for 30 minutes and washed three times with RPMI 1640 medium) BALB/Cstimulator cells (H-2d) in 0.2 ml RPMI 1640 medium supplemented with 10% fetal calf serum, 2 mMsodium bicarbonate, benzylpenicillin (50 u/ml) and streptomycin (50^g/ml). The cells were incubated at 37°C in a humidified atmosphere of 5% CO2: 95% air for 68 hours and pulsed with [3H]thymidine ([3H]TdR) (0.5^Ci) 4 hours before the cells were collected. The test compoundswere dissolved in ethanol at 1 mMand further diluted in RPMI1640 mediumand added to the cultures.
Plaque Forming Cell (PFC) Assay PFCAssay: C3H/Hemice were immunized on day 0 with 0.2 ml of 1 X 108 washed sheep erythrocytes intravenously. Spleens were removedon day 4 and spleen cells were incubated in the presence of sheep red blood cells as described by Cunninghamand Szenberg.u) Tests were evaluated by enumeration of direct generated PFC's in the presence of complement. The numberof spleen cells was counted with a Microcell counter CC-130 (Sysmex, Japan) and PFC results were calculated as PFC/106 recovered cells and PFC/spleen. Drug Treatment : Drugs were administered orally for 4 days starting from the day of immunization. Delayed Type Hypersensitivity
Response to Methylated Bovine Serum Albumin (MBSA) BDFXmice were sensitized with a subcutaneous injection of 0.1 ml emulsion consisting of equal volume of MBSA(2mg/ml) and Freund's incomplete adjuvant. Seven days later, a 0.05-ml challenge dose of 0.4 mg/mlMBSA in saline was injected into the plantar region of the right hind foot and 0.05 ml saline into the left hind foot to act as a control. Twenty four hours after challenge, both hind feet were measured with a dial gauge and the mean challenge in footpad thickness was measured. Drugs were injected for 8 days orally, starting from the day of sensitization.
Localized Graft-vs-host Reaction (GvHR) Spleen cells prepared from C57BL/6 mice were slowly injected into the right footpad of BDF: mice as recipients at 107 cells/mouse. Seven days later, the recipients were sacrificed and popliteal lymph nodes were removed from both extremities. The increase in lymph node weight due to the GvHRwas measured as a difference between the popliteal lymph node weight of right (injected) leg and the popliteal lymph node weight of left (uninjected) leg. Drugs were administered orally for 5 days after injection of allogenic spleen cells.
Statistical Analysis
The results of each experiment were evaluated using Student's t-test.
Results Fermentation The time course of FK-506 production by Streptomyces tsukubaensis No. 9993 in a 2-kiloliter tank is shown in Fig. 2 . The organism reached the stationary phase of growth after a 40-hour incubation. FK-506 production began at 40 hours, and the maximumaccumulation was observed after a 90-hour incubation period. The pH of the medium during incubation fell to 6.2 and then began to rise gradually to 7.3 with the maximumaccumulation of the compound.
Isolation Procedure The flow diagram of the isolation procedure described below is shown in Fig. 3 . The cultured broth (1,500 liters) was filtered with the aid of diatomaceous earth (25 kg). The mycelial cake was extracted with acetone (500 liters), yielding 500 liters of the extract. The acetone extract from the mycelium and the filtrate (1,350 liters) were combined and passed through a column of a non-ionic adsorption resin Diaion HP-20 (Mitsubishi Chemical Industries Ltd., Japan) (100 liters).
After washing with water (300 liters) and 50% aqueous acetone (300 liters), elution was carried out with SEPT. 1987 75 %aqueous acetone. The eluate was evaporated under reduced pressure to give residual aqueous solution (300 liters). This residue was extracted with ethyl acetate (20 liters) three times. The ethyl acetate extract was concentrated under reduced pressure to give an oily residue. The oily residue was mixed with twice its weight of acidic silica gel (special silica gel grade 12, Fuji Devison Co., Japan), and this mixture was slurried in ethyl acetate. After the solvent was evaporated, the resultant dry powder was subjected to column chromatography of the same acidic silica gel (8 liters) which was packed with fz-hexane. The column was developed with n-hexane (30 liters), a mixture of w-hexane and ethyl acetate (4 : 1, 30 liters) and ethyl acetate (30 liters). The fractions containing FK-506 were collected and concentrated under reduced pressure to give an oily residue. The oily residue was mixed with twice its weight of acidic silica gel and this mixture was slurried in ethyl acetate. After the solvent was evaporated, the resultant dry powder was rechromatographed on acidic silica gel (3.5 liters) packed with w-hexane. The column was developed with w-hexane (10 liters), a mixture of /z-hexane and ethyl acetate (4 : 1, 10 liters) and ethyl acetate (10 liters). Fractions containing FK-506 were collected and concentrated under reduced pressure to give an yellowish oil. The oily residue was dissolved in a mixture of w-hexane and ethyl acetate (1 : 1, 300 ml) and subjected to column chromatography of silica gel (230~400 mesh, Merck Co., Ltd., U.S.A.) (2 liters) packed with the same solvent system. Elution was carried out with a mixture of w-hexane and ethyl acetate (1 : 1, 10 liters and 1 : 2, 6 liters) and ethyl acetate (6 liters).
Fractions containing FK-506 were collected and concentrated under reduced pressure to give FK-506 in the form of white powder (34 g). This white powder was dissolved in acetonitrile and concentrated under reduced pressure. This concentrate was kept at 5°C overnight and prisms (22.7 g) were obtained. Recrystallization from the same solvent gave purified FK-506 (13.6 g) as colorless prisms.
Physico Table 2 . The determination of the chemical structure of FK-506 will be described elsewhere.10)
Biological
Properties Antimicrobial Activities
The antimicrobial activities are shown in Table 3 . FK-506 shows antifungal activity against FK-506 (a), CS (O) and PRD (à") were added directly throughout the assay.
Aspergillus fumigatus and Fusanum oxysporum. It has no inhibitory effect on bacteria or yeast.
Suppression of MLR  Fig. 4 shows the suppressive effect of various concentrations of FK-506, CS and PRDon mouse MLR. The IC50 values (the concentration causing 50% inhibition) under present study conditions, were 0.32 nM, 27 dm and 17 dm, respectively. FK-506 shows much higher activity than CS and PRDon suppression of mouse MLR. Further details of in vitro immunosuppressive effect concerning FK-506 will be published in the succeeding paper.12) Suppressive Effect on Humoral and Cellular Immunity in Mice As shown in Table 4 , oral administration of FK-506 and CS strongly suppressed PFC response, but slightly decreased the number of spleen cells. Consequently both compoundsstrongly suppressed humoral immunity (antibody production) with marginal decrease in the number of spleen cells. The ED50 values (the dose causing 50% effect) of FK-506 and CS were 4.4 mg/kg and 39 mg/kg, respectively. FK-506 showed higher activity than CS on PFC response in mice.
As shown in Table 5 , oral treatment with FK-506 and CS strongly suppressed the DTHresponse, therefore both compounds strongly suppressed cellular immunity. The ED50values were 14 mg/kg and 40 mg/kg, respectively. FK-506 again showed higher activity than CS on the DTHresponse in mice.
Suppressive Effect on Localized GvHRin Mice The effect of FK-506 and CS on the localized GvHRwas examined by oral administration of both drugs to BDFXmice for 5 days after injection of spleen cells from C57BL/6 mice into the footpads. The results of GvHRwere shown in Table 6 . Treatment with FK-506 at doses of 10 mg/kg or more resulted in a significant weight reduction of popliteal lymph nodes from the injection site of allogenic cells. CS also inhibited GvHR, but it was less active on GvHRthan was FK-506. 
Di s cussion
CS is a metabolite extracted from a fungus and is a cyclic polypeptide consisting of 1 1 amino acids.13) On the other hand, FK-506 is a metabolite extracted from a Streptomyces and is a neutral macrolide as shown in Fig. 1 . So, the chemical structure of FK-506 is entirely different from that of CS. FK-506 inhibits the production of T cell-derived soluble mediators such as IL-2, IL-3 and IFN-f as does CS. These in vitro actions of FK-506 will be published in the succeeding paper.12) Fig. 4 effect of FK-506 on mouse MLR,which has been thought to be the representative of IL-2 dependent T cell growth.14) This compound has much higher potency than CS on mouse MLR.Furthermore, oral administration of FK-506 strongly suppressed both the production of antibody to SRBC (Table 4) and the DTHresponse to MBSAin mice (Table 5) . It also inhibited GvHRinduced by the injection of allogenic cells in mice (Table 6) . These results clearly demonstrate that FK-506 is capable of inhibiting the humoral and cellular immunity and alloantigen-driven proliferation across strong histocompatibility barriers. Moreover these results suggest that FK-506 has much higher potency than CS not only in vitro but also in vivo. This leads us to conclude that FK-506 has profound immunosuppressive properties in vitro and in vivo, and it is one of the most active immunosuppressants. Further details of in vivo effects of the agent on the graft rejection in organ transplantation will be published in a separate paper. 15) 
